Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 9

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 9 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 9 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Related articles

Page: 1

Published online: 14 Aug 2012

53 Views
0 CrossRef citations
0Altmetric

Editorial

Pregabalin in clinical psychiatry and addiction: pros and cons

Giovanni Martinotti

Pages: 1243-1245

Published online: 24 Jun 2012

AbstractforPregabalin in clinical psychiatry and addiction: pros and cons | Full Text | References | PDF (150.7 KB)

4521 Views
29 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

Mital Patel MD, Michael A Vogelbaum MD, Gene H Barnett MD, Rakesh Jalali MD & Manmeet S Ahluwalia MD

Pages: 1247-1266

Published online: 25 Jun 2012

AbstractforMolecular targeted therapy in recurrent glioblastoma: current challenges and future directions | Full Text | References | PDF (534.5 KB)

1010 Views
42 CrossRef citations
0Altmetric

Review Article

Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis

Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt & Péter Mátyus

Pages: 1267-1308

Published online: 28 Jun 2012

AbstractforClinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis | Full Text | References | PDF (1.1 MB)

1283 Views
75 CrossRef citations
0Altmetric

Review Article

Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders

Cristoforo Silvestri & Vincenzo Di Marzo

Pages: 1309-1322

Published online: 11 Jul 2012

AbstractforSecond generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders | Full Text | References | PDF (227.9 KB)

1131 Views
65 CrossRef citations
0Altmetric

Review Article

Targeting memory processes with drugs to prevent or cure PTSD

Christopher K. Cain, George D. Maynard & John H. Kehne

Pages: 1323-1350

Published online: 27 Jul 2012

AbstractforTargeting memory processes with drugs to prevent or cure PTSD | Full Text | References | PDF (569.8 KB)

1471 Views
38 CrossRef citations
0Altmetric

Review Article

Targeting TRPV1 for pain relief: limits, losers and laurels

Arpad Szallasi & Mohamed Sheta

Pages: 1351-1369

Published online: 11 Jul 2012

AbstractforTargeting TRPV1 for pain relief: limits, losers and laurels | Full Text | References | PDF (427.5 KB)

1292 Views
110 CrossRef citations
0Altmetric

Review Article

New AMPA antagonists in epilepsy

Emilio Russo, Rosaria Gitto, Rita Citraro, Alba Chimirri & Giovambattista De Sarro MD

Pages: 1371-1389

Published online: 13 Jul 2012

AbstractforNew AMPA antagonists in epilepsy | Full Text | References | PDF (410.3 KB)

664 Views
45 CrossRef citations
0Altmetric

Drug Evaluations

Article

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

Sharon Berendsen, Marike Broekman, Tatjana Seute, Tom Snijders, Corine van Es, Filip de Vos, Luca Regli & Pierre Robe

Pages: 1391-1415

Published online: 06 Jun 2012

Abstractfor Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results | Full Text | References | PDF (456.1 KB)

716 Views
54 CrossRef citations
0Altmetric

Article

Sorafenib in non-small cell lung cancer

Jianjun Zhang MD PhD, Kathryn A Gold MD & Edward Kim MD

Pages: 1417-1426

Published online: 24 Jun 2012

Abstractfor Sorafenib in non-small cell lung cancer | Full Text | References | PDF (227.1 KB)

597 Views
21 CrossRef citations
0Altmetric

Article

Dalcetrapib, a cholesteryl ester transfer protein modulator

Amanda J Hooper & John R Burnett

Pages: 1427-1432

Published online: 24 Jun 2012

Abstractfor Dalcetrapib, a cholesteryl ester transfer protein modulator | Full Text | References | PDF (208.1 KB)

269 Views
16 CrossRef citations
0Altmetric

Meeting Highlights

Article

Cambridge Healthtech Institute's Third Annual Anti-inflammatories: Small Molecules Meeting, April 17^th – 18^th 2012, San Diego, USA

Martin Braddock BSc PhD

Pages: 1433-1444

Published online: 13 Jul 2012

AbstractforCambridge Healthtech Institute's Third Annual Anti-inflammatories: Small Molecules Meeting, April 17^th – 18^th 2012, San Diego, USA | Full Text | References | PDF (237.8 KB)

179 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

From bench to bedside - is there a role of IL-17 drugs in rheumatoid arthritis?

Swetha Byravan et al.

Review Article | Published online: 9 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.9, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?